Archive · 13 Aug 2025
Eli Lilly Launches Mounjaro KwikPen in India
Eli Lilly now offers Mounjaro in India using a pen-like device called KwikPen.
This pen provides a weekly dose and has different strengths to personalize treatment.
Prices vary depending on the strength, ranging from ₹14,000 to ₹27,500 for a month's supply.
Novo Nordisk's Wegovy is another option, also available in a pen format with similar pricing.
Eli Lilly launched Mounjaro KwikPen in India.
The KwikPen is a multi-dose, prefilled pen for single-patient use.
It is available in six strengths.
Prices range from ₹14,000 to ₹27,500 per month.
Novo Nordisk's Wegovy is also available in a similar pen format.
- Who
- Eli Lilly
- What
- Eli Lilly launched Mounjaro KwikPen in India.
- When
- August 2025
- Where
- India
- Why
- To provide a more convenient treatment option and compete in the market.
Market Competition
Pricing and Convenience
Market Share
Market Competition
Eli Lilly is launching Mounjaro KwikPen to compete with Novo Nordisk.
Pricing and Convenience
Novo Nordisk also launched Wegovy.
- Drug Name
- Mounjaro KwikPen
- Purpose
- Type 2 diabetes and weight loss
- Administration
- Prefilled pen, once weekly
- Dose Strengths
- 2.5 mg to 15 mg
- Market
- Indian pharmaceutical market
- Competitor
- Novo Nordisk (Wegovy)
- Price
- ₹14,000 - ₹27,500 (monthly supply)
Sources
Eli Lilly Launches Mounjaro KwikPen in India; Is It Better Than Taking a Jab to Battle Diabetes and Obesity?
Eli Lilly’s diabetes and weight loss drug Mounjaro available in a pen-like device across India
Eli Lilly launches Mounjaro KwikPen for diabetic and obese patients in India – Check doses, prices and how it works
Eli Lilly launches Mounjaro pen in India as obesity drug race heats up
